GOLDMAN SACHS GROUP INC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 43 filers reported holding APREA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$54,000
-20.6%
29,109
+22.2%
0.00%
Q4 2021$68,000
-90.8%
23,824
-83.5%
0.00%
Q3 2021$740,000
+142.6%
144,758
+131.4%
0.00%
Q2 2021$305,000
-18.2%
62,546
-14.4%
0.00%
Q1 2021$373,000
-53.1%
73,107
+121.1%
0.00%
Q3 2020$795,000
-24.0%
33,059
+22.6%
0.00%
Q2 2020$1,046,000
+149.0%
26,972
+123.2%
0.00%
Q1 2020$420,00012,0860.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 48,819$36,0000.01%
Quantamental Technologies LLC 11,352$9,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 45,000$33,0000.00%
Tower Research Capital LLC (TRC) 47,362$36,0000.00%
Virtu Financial LLC 19,664$15,0000.00%
Sugarloaf Wealth Management, LLC 5,000$4,0000.00%
Bank of New York Mellon Corp 16,643$12,0000.00%
Blackstone Inc. 16,590$12,0000.00%
Citadel Advisors 365,900$271,0000.00%
Citadel Advisors 12,000$9,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders